About this trial
In this project the investigators aim to identify new biological markers by characterizing the response/inflammation associated with the development and progression of M. abscessus lung disease in patients suffering from cystic fibrosis with the aim of increasing current knowledge available on the development and progression of lung disease.
Eligibility criteria
Qualifiers
Patients with a certain diagnosis of cystic fibrosis and visited during normal clinical practice, in accordance with the standard operating procedures in force at the Centres.
Both sexes
Age >18 years
Obtaining informed consent for patients (based on the procedures established by the protocol).
Disqualifiers
Patients unable to understand the instructions and information provided and be able to adequately accept the study methods.
Trial design
Treatments tested in this trial
- Luminex; scRNAsec
Treatment groups
Sponsors and collaborators
Ospedale San Raffaele
Lead sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborator